What have been the federal government's activities in the area of hepatitis B vaccination, specifically: ( a ) information learned by Health Protection Branch regulators from the decision by France to suspend the administration of the hepatitis B vaccination; ( b ) actions taken by Health Canada to assess safety of the vaccination B product and, in particular, to survey for adverse reactions over and above voluntary reporting; ( c ) information requested and received from international bodies such as the World Health Organization about the safety of the hepatitis B vaccination; ( d ) reassessment of existing evidence in the new drug submission for the hepatitis B vaccination previously assessed; and ( e ) evidence that plasma was not involved in any part of the manufacturing of the hepatitis B vaccination?
In the House of Commons on April 13th, 1999. See this statement in context.